Nanobodies Targeting the Hepatocyte Growth Factor: Potential New Drugs for Molecular Cancer Therapy

M.J.W.D. Vosjan, J. Vercammen, J.A. Kolkman, M. Stigter-van Walsum, H. Revets, G.A.M.S. van Dongen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1017-1025
JournalMolecular Cancer Therapeutics
Volume11
Issue number4
DOIs
Publication statusPublished - 2012

Cite this

Vosjan, M.J.W.D. ; Vercammen, J. ; Kolkman, J.A. ; Stigter-van Walsum, M. ; Revets, H. ; van Dongen, G.A.M.S. / Nanobodies Targeting the Hepatocyte Growth Factor: Potential New Drugs for Molecular Cancer Therapy. In: Molecular Cancer Therapeutics. 2012 ; Vol. 11, No. 4. pp. 1017-1025.
@article{6b6272a96f46414ebfb402c8466956c3,
title = "Nanobodies Targeting the Hepatocyte Growth Factor: Potential New Drugs for Molecular Cancer Therapy",
author = "M.J.W.D. Vosjan and J. Vercammen and J.A. Kolkman and {Stigter-van Walsum}, M. and H. Revets and {van Dongen}, G.A.M.S.",
year = "2012",
doi = "10.1158/1535-7163.MCT-11-0891",
language = "Undefined/Unknown",
volume = "11",
pages = "1017--1025",
journal = "Molecular Cancer Therapeutics",
issn = "1535-7163",
publisher = "American Association for Cancer Research Inc.",
number = "4",

}

Nanobodies Targeting the Hepatocyte Growth Factor: Potential New Drugs for Molecular Cancer Therapy. / Vosjan, M.J.W.D.; Vercammen, J.; Kolkman, J.A.; Stigter-van Walsum, M.; Revets, H.; van Dongen, G.A.M.S.

In: Molecular Cancer Therapeutics, Vol. 11, No. 4, 2012, p. 1017-1025.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Nanobodies Targeting the Hepatocyte Growth Factor: Potential New Drugs for Molecular Cancer Therapy

AU - Vosjan, M.J.W.D.

AU - Vercammen, J.

AU - Kolkman, J.A.

AU - Stigter-van Walsum, M.

AU - Revets, H.

AU - van Dongen, G.A.M.S.

PY - 2012

Y1 - 2012

U2 - 10.1158/1535-7163.MCT-11-0891

DO - 10.1158/1535-7163.MCT-11-0891

M3 - Article

VL - 11

SP - 1017

EP - 1025

JO - Molecular Cancer Therapeutics

JF - Molecular Cancer Therapeutics

SN - 1535-7163

IS - 4

ER -